These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8314479

  • 1. Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
    Piazza M, Orlando R, Tosone G, Tiseo D, Conte MC, Minervini F, Santoro G, Scordino F, Vitale D.
    Gut; 1993; 34(2 Suppl):S128-9. PubMed ID: 8314479
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
    De Bac C, Grimaldi F, Clementi C, Duca F, Livoli D, Taliani G.
    Gut; 1993; 34(2 Suppl):S135. PubMed ID: 8314480
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical and histological evaluation of interferon alfa-2b in the treatment of chronic hepatitis C.
    Panella C, Francavilla A, Conte D, Tatulli I, Rubini F.
    Gut; 1993; 34(2 Suppl):S127. PubMed ID: 8314478
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
    Lindsay KL, Davis GL, Schiff ER, Bodenheimer HC, Balart LA, Dienstag JL, Perrillo RP, Tamburro CH, Goff JS, Everson GT, Silva M, Katkov WN, Goodman Z, Lau JY, Maertens G, Gogate J, Sanghvi B, Albrecht J.
    Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High dose interferon treatment in chronic hepatitis C.
    Iino S.
    Gut; 1993 Nov; 34(2 Suppl):S114-8. PubMed ID: 8314475
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A controlled study to determine the optimal dose regimen of interferon-alpha 2b in chronic hepatitis C.
    Hakozaki Y, Shirahama T, Katou M, Nakagawa K, Oba K, Mitamura K.
    Am J Gastroenterol; 1995 Aug; 90(8):1246-9. PubMed ID: 7639224
    [Abstract] [Full Text] [Related]

  • 13. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course.
    Reichard O, Glaumann H, Norkrans G, Wejstål R, Fryden A, Schvarcz R, Weiland O.
    Liver; 1994 Aug; 14(4):169-74. PubMed ID: 7526108
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.
    Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, Heyraud JP, Fontanges T, Albrecht J, Meschievitz C.
    Gastroenterology; 1991 Aug; 101(2):497-502. PubMed ID: 1906028
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Benelux multicentre trial of alpha interferon treatment for chronic hepatitis C: standard v high dose treatment monitored by biochemical and virological markers (interim analysis). Benelux Multicentre Trial Study Group.
    Gut; 1993 Aug; 34(2 Suppl):S119-20. PubMed ID: 8390952
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.